1063 related articles for article (PubMed ID: 16639051)
1. Financial conflict of interest disclosure and voting patterns at Food and Drug Administration Drug Advisory Committee meetings.
Lurie P; Almeida CM; Stine N; Stine AR; Wolfe SM
JAMA; 2006 Apr; 295(16):1921-8. PubMed ID: 16639051
[TBL] [Abstract][Full Text] [Related]
2. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
Lurie P
MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
[No Abstract] [Full Text] [Related]
3. Revisiting financial conflicts of interest in FDA advisory committees.
Pham-Kanter G
Milbank Q; 2014 Sep; 92(3):446-70. PubMed ID: 25199895
[TBL] [Abstract][Full Text] [Related]
4. Financial Conflicts of Interest at FDA Drug Advisory Committee Meetings.
Hayes MJ; Prasad V
Hastings Cent Rep; 2018 Mar; 48(2):10-13. PubMed ID: 29590518
[TBL] [Abstract][Full Text] [Related]
5. Association of Appearance of Conflicts of Interest With Voting Behavior at FDA Advisory Committee Meetings-A Cross-sectional Study.
Xu J; Emenanjo O; Ortwerth M; Lurie P
JAMA Intern Med; 2017 Jul; 177(7):1038-1040. PubMed ID: 28464118
[TBL] [Abstract][Full Text] [Related]
6. Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration.
Tibau A; Ocana A; Anguera G; Seruga B; Templeton AJ; Barnadas A; Amir E
JAMA Oncol; 2016 Jun; 2(6):744-50. PubMed ID: 26940233
[TBL] [Abstract][Full Text] [Related]
7. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
Steinbrook R
N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
[No Abstract] [Full Text] [Related]
8. Does seating location impact voting behavior on Food and Drug Administration advisory committees?
Broniatowski DA; Magee CL
Am J Ther; 2013; 20(5):502-6. PubMed ID: 21642834
[TBL] [Abstract][Full Text] [Related]
9. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations.
Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
Cochrane Database Syst Rev; 2020 Dec; 12(12):MR000040. PubMed ID: 33289919
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and conflicts of interests of public speakers at the Psychopharmacologic Drug and Advisory Committee meetings regarding psychiatric drugs.
Roberts W; Jellison S; Wayant C; Vassar M
BMJ Evid Based Med; 2020 Aug; 25(4):145-146. PubMed ID: 32019896
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and conflicts of interest at Food and Drug Administration Gastrointestinal Drug Advisory Committee meetings.
Khan R; Elsolh K; Gimpaya N; Scaffidi MA; Bansal R; Grover SC
PLoS One; 2021; 16(5):e0252155. PubMed ID: 34038480
[TBL] [Abstract][Full Text] [Related]
12. Probity gone nuts.
Nat Biotechnol; 2007 May; 25(5):483. PubMed ID: 17483818
[TBL] [Abstract][Full Text] [Related]
13. Public Speaker Characteristics at Meetings of the Dermatologic and Ophthalmic Drug Advisory Committee and the Ophthalmic Devices Panel.
Khattab MH; Weaver M; Cook C; Kinder N; Vassar M
Am J Ophthalmol; 2021 Mar; 223():28-32. PubMed ID: 33166500
[TBL] [Abstract][Full Text] [Related]
14. Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
Lietzan E
J Health Law; 2006; 39(4):415-49. PubMed ID: 17402656
[TBL] [Abstract][Full Text] [Related]
15. The Potential Effects of Financial Conflicts of Interest of Speakers at the US Food and Drug Administration's Pulmonary-Allergy Drug Advisory Committee Meetings.
Bickford T; Kinder N; Arthur W; Wayant C; Vassar M
Chest; 2021 Jun; 159(6):2399-2401. PubMed ID: 33171160
[No Abstract] [Full Text] [Related]
16. Association Between Food and Drug Administration Advisory Committee Recommendations and Agency Actions, 2008-2015.
Zhang AD; Schwartz JL; Ross JS
Milbank Q; 2019 Sep; 97(3):796-819. PubMed ID: 31304643
[TBL] [Abstract][Full Text] [Related]
17. Association between conflicts of interest and favourable recommendations in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: systematic review.
Nejstgaard CH; Bero L; Hróbjartsson A; Jørgensen AW; Jørgensen KJ; Le M; Lundh A
BMJ; 2020 Dec; 371():m4234. PubMed ID: 33298430
[TBL] [Abstract][Full Text] [Related]
18. Financial conflicts of interest during meetings of the cardiovascular and renal drugs advisory committee.
Bertolino B; Kinder N; Cooper C; Gray H; Arthur W; Ahlander J; Simpson A; Vassar M
J Osteopath Med; 2022 Sep; 122(9):445-451. PubMed ID: 35447023
[TBL] [Abstract][Full Text] [Related]
19. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study.
Elder K; Turner KA; Cosgrove L; Lexchin J; Shnier A; Moore A; Straus S; Thombs BD
CMAJ; 2020 Jun; 192(23):E617-E625. PubMed ID: 32538799
[TBL] [Abstract][Full Text] [Related]
20. Conflict of Interest in Practice Guidelines Panels.
Sox HC
JAMA; 2017 May; 317(17):1739-1740. PubMed ID: 28464160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
